In liver sections from patients with fibrosis and cirrhosis, it has been reported that hepatic stellate cells upregulate ADAMs and subsequently lead to the release of soluble fractalkine that recruits inflammatory cells to the liver and contributes to increased liver pathology [44]. Here, CX3CL1 is linked to Cirrhosis.